What 4 Analyst Ratings Have To Say About Bluebird Bio
What 4 Analyst Ratings Have To Say About Bluebird Bio
bluebird bio (NASDAQ:BLUE) has observed the following analyst ratings within the last quarter:
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 0 | 3 | 1 | 0 |
Last 30D | 0 | 0 | 0 | 1 | 0 |
1M Ago | 0 | 0 | 2 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 1 | 0 | 0 |
According to 4 analyst offering 12-month price targets in the last 3 months, bluebird bio has an average price target of $7.25 with a high of $9.00 and a low of $4.00.
Below is a summary of how these 4 analysts rated bluebird bio over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock
This current average represents a 75.83% decrease from the previous average price target of $30.00.
Stay up to date on bluebird bio analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
How Are Analyst Ratings Determined?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
bluebird bio (NASDAQ:BLUE) has observed the following analyst ratings within the last quarter:
bluebird bio(纳斯达克股票代码:BLUE)在上个季度观察到以下分析师评级:
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 0 | 3 | 1 | 0 |
Last 30D | 0 | 0 | 0 | 1 | 0 |
1M Ago | 0 | 0 | 2 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 1 | 0 | 0 |
看涨 | 有点看涨 | 冷漠 | 有点看跌 | 看跌 | |
---|---|---|---|---|---|
总收视率 | 0 | 0 | 3 | 1 | 0 |
最后 30 天 | 0 | 0 | 0 | 1 | 0 |
1 月前 | 0 | 0 | 2 | 0 | 0 |
2 万之前 | 0 | 0 | 0 | 0 | 0 |
3 万之前 | 0 | 0 | 1 | 0 | 0 |
According to 4 analyst offering 12-month price targets in the last 3 months, bluebird bio has an average price target of $7.25 with a high of $9.00 and a low of $4.00.
根据4位分析师在过去3个月中提供12个月目标价格,bluebird bio的平均目标价为7.25美元,最高为9.00美元,低点为4.00美元。
Below is a summary of how these 4 analysts rated bluebird bio over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock
以下是这4位分析师在过去3个月中对bluebird bio的评级摘要。看涨评级的数量越多,分析师对该股的看法就越积极,看跌评级的数量越多,分析师对该股的负面评价就越多
This current average represents a 75.83% decrease from the previous average price target of $30.00.
目前的平均价格比之前的平均目标价30.00美元下降了75.83%。
Stay up to date on bluebird bio analyst ratings.
随时了解蓝鸟生物分析师评级.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
如果你有兴趣关注小盘股的新闻和表现,可以先在这里追踪。
How Are Analyst Ratings Determined?
分析师评级是如何确定的?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
分析师在银行和金融系统工作,通常专门研究股票或特定行业的报告。分析师可以参加公司电话会议和会议,研究公司财务报表,并与内部人士沟通,公布股票的 “分析师评级”。分析师通常每季度对每只股票进行一次评级。
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
一些分析师还将提供增长预期、收益和收入等指标的预测,以为股票提供进一步指导。使用分析师评级的投资者应注意,这种专业建议来自人类,可能会出错。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成,并由编辑审阅。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧